Afterpay Ltd (ASX:APT) and Uniti Group Ltd (ASX:UWL) shares are two of four storming higher on Tuesday. Here’s why…
The post Why Afterpay, Clinuvel, Mesoblast, & Uniti shares are storming higher appeared first on Motley Fool Australia. –
In late morning trade the S&P/ASX 200 Index (ASX: XJO) is just managing to keep its head above water. At the time of writing, the benchmark index is up 0.1% to 5,905.7 points.
Four shares that are climbing more than most today are listed below. Here’s why they are storming higher:
The Afterpay Ltd (ASX: APT) share price is back on form and is charging 4% higher to $75.47. Investors have been buying the buy now pay later provider’s shares after a rebound on the tech-focused Nasdaq index overnight. It isn’t just Afterpay on the rise in the tech sector today. At the time of writing, the S&P/ASX All Technology Index (ASX: XTX) is up 1.5%.
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is up 4% to $22.18. This morning the biopharmaceutical company released an update on its attempts to expand the use of its SCENESSE drug to treat xeroderma pigmentosum (XP). This morning it revealed that the first patient diagnosed with XP has been administered the drug under a Special Access Program. Initially the company will be focused on its safety. If this is successful, it will conduct two further studies to test its efficacy.
The Mesoblast limited (ASX: MSB) share price has jumped 7% to $4.98. This follows the release of an announcement relating to its lead product candidate remestemcel-L. That announcement reveals that the product has been selected as the winner of the Fierce Innovation Awards – Life Sciences Edition 2020 for Biotech Innovation.
The Uniti Group Ltd (ASX: UWL) share price is up almost 15% to $1.40. Investors have been buying the company’s shares after it made an improved offer to acquire fellow telco OptiComm Ltd (ASX: OPC). Uniti has matched an offer of $5.85 per share made by First State Super last week. In light of this, Uniti and OptiComm have entered into an amended and restated scheme implementation deed.
These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.
*Returns as of 6/8/2020
- Uniti (ASX:UWL) share price surges higher on revised OptiComm (ASX:OPC) takeover offer
- Have we reached “peak” Afterpay (ASX:APT) as its US website growth stalls?
- Why the Clinuvel (ASX:CUV) share price is storming higher today
- Buy Afterpay (ASX:APT) and these ASX shares before the tech rebound
- 5 things to watch on the ASX 200 on Tuesday
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Why Afterpay, Clinuvel, Mesoblast, & Uniti shares are storming higher appeared first on Motley Fool Australia.